Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Benitec Biopharma (BNTC) Leases (2019 - 2025)

Benitec Biopharma's Leases history spans 6 years, with the latest figure at $137000.0 for Q4 2024.

  • For Q4 2024, Leases fell 65.75% year-over-year to $137000.0; the TTM value through Dec 2024 reached $137000.0, down 65.75%, while the annual FY2024 figure was $270000.0, 48.67% down from the prior year.
  • Leases for Q4 2024 was $137000.0 at Benitec Biopharma, down from $204000.0 in the prior quarter.
  • Across five years, Leases topped out at $947000.0 in Q3 2021 and bottomed at $137000.0 in Q4 2024.
  • The 5-year median for Leases is $463000.0 (2023), against an average of $515000.0.
  • The largest annual shift saw Leases soared 228.57% in 2022 before it tumbled 65.75% in 2024.
  • A 5-year view of Leases shows it stood at $300000.0 in 2020, then skyrocketed by 196.0% to $888000.0 in 2021, then decreased by 26.8% to $650000.0 in 2022, then crashed by 38.46% to $400000.0 in 2023, then crashed by 65.75% to $137000.0 in 2024.
  • Per Business Quant, the three most recent readings for BNTC's Leases are $137000.0 (Q4 2024), $204000.0 (Q3 2024), and $270000.0 (Q2 2024).